Dietary phospholipids ameliorate fructose-induced hepatic lipid and metabolic abnormalities in rats

Journal of Nutrition

Volumn 141, Issue 11, 2011, Pages 2003-2009

  Mori, Takuya ^a   Kondo, Hidehiko ^a   Hase, Tadashi ^a   Murase, Takatoshi ^a  

^a KAO CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; FRUCTOSE; GLUCOSE; MESSENGER RNA; NUCLEAR PROTEIN; OLEIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LIPID LIVER LEVEL; LIPOGENESIS; METABOLIC DISORDER; NONHUMAN; RAT; SOYBEAN;

ANIMALS; CELL LINE, TUMOR; DIETARY FATS; FRUCTOSE; HUMANS; LIPOGENESIS; LIVER; MALE; METABOLISM; PHOSPHOLIPIDS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

GLYCINE MAX; RATTUS;

EID: 81055126867     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.143602     Document Type: Article

References (42)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Finding from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
2. Friedman J. Fat in all the wrong places. Nature. 2002;415:268-9.
3. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319-36.
4. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450-5.
5. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87:3023-8.
6. Yki-Järvinen H. Fat in the liver and insulin resistance. Ann Med. 2005; 37:347-56.
7. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004;279:32345-53.
8. Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest. 2007;117:739-45.
9. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, et al. Tissue-specific over-expression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA. 2001;98:7522-7.
10. Schaffer JE. Lipotoxicity: when tissue overeat. Curr Opin Lipidol. 2003; 14:281-7.
11. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and insulin resistance syndrome. Am J Clin Nutr. 2002;76:911-22.
12. Gaby AR. Adverse effect of dietary fructose. Altern Med Rev. 2005;10: 294-306.
13. Daly ME, Vale C, Walker M, Alberti KG, Mathers JC. Dietary carbohydrates and insulin sensitivity. Am J Clin Nutr. 1997;66:1072-85.
14. Sleder J, Chen YD, Cully MD, Reaven GM. Hyperinsulinemia in fructose-induced hypertriglyceridemia in the rat. Metabolism. 1980;29:303-5.
15. Faeh D, Minehira K, Schwarz JM, Periasami R, Seongsu P, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes. 2005; 54:1907-13.
16. Nagata R, Nishio Y, Sekine O, Nagai Y, Maeno Y, Ugi S, Maegawa H, Kashiwagi A. Single nucleotide polymorphism (-468 Gly to Ala) at the promoter region of sterol regulatory element-binding protein-1c associates with genetic defect of fructose-induced hepatic lipogenesis. J Biol Chem. 2004;279:29031-42.
17. Koo HY, Wallig MA, Chung BH, Nara TY, Cho BH, Nakamura MT. Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim Biophys Acta. 2008;1782:341-8.
18. Miyazaki M, Flowers MT, Sampath H, Chu K, Otzelberger C, Liu X, Ntambi JM. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 2007;6:484-96.
19. Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, Inoue N, Ishikawa M, Okada S, Ishigaki N, et al. Crucial role of long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med. 2007;13:1193-202.
20. Murata M, Imaizumi K, Sugano M. Effect of dietary phospholipids and their constituent bases on serum lipids and apolipoproteins in rats. J Nutr. 1982;112:1805-8.
21. Tompkins RK, Parkin LG. Effects of long-term ingestion of soya phospholipids on serum lipids in humans. Am J Surg. 1980;140:360-4.
22. Ide T, Murata M. Depressions by dietary phospholipids of soybean and egg yolk origins of hepatic triacylglycerol and fatty acid synthesis in fasted-refed rats. Ann Nutr Metab. 1994;38:340-8.
23. Rouyer IA, Takahashi Y, Ide T. Dietary phospholipid-dependent reductions in gene expression and activity of liver enzymes in fatty acid synthesis in fasted-refed rats. J Nutr Sci Vitaminol (Tokyo). 1999; 45:287-302.
24. Kondo H, Minegishi Y, Komine Y, Mori T, Matsumoto I, Abe K, Tokimitsu I, Hase T, Murase T. Differential regulation of intestinal metabolism-related genes in obesity-resistant A/J versus obesity-prone C57BL/6J mice. Am J Physiol Endocrinol Metab. 2006;291:E1092-9.
25. Turinsky J, Bayly BP, O'Sullivan DM. 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. J Biol Chem. 1990;265: 7933-8.
26. Sattler W, Puhl H, Hayn M, Kostner GM, Esterbauer H. Determination of fatty acids in the main lipoprotein classes by capillary chromatography: BF3/methanol transesterification of lyophilized samples instead of Folch extraction gives higher yields. Anal Biochem. 1991;198:184-90.
27. Lo S, Russell JC, Taylor AW. Determination of glycogen in small tissue samples. J Appl Physiol. 1970;28:234-6.
28. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem. 1998;273:35299-306.
29. Kumar S, Dorsey JA, Muesing RA, Porter JW. Comparative studies of the pigeon liver fatty acid synthetase complex and its subunits. J Biol Chem. 1970;245:4732-44.
30. Tanabe T, Nakanishi S, Hashimoto T, Ogiwara H, Nikawa J, Numa S. Acetyl-CoA carboxylase from rat liver. Methods Enzymol. 1981;71:5-16.
31. Miyazaki M, Kim YC, Gray-Keller MP, Attie AD, Ntambi JM. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem. 2000;275:30132-8.
32. Matsuzaka T, Shimano H, Yahagi N, Yoshikawa T, Amemiya-Kudo M, Hasty AH, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, et al. Cloning and characterization of mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. J Lipid Res. 2002;43:911-20.
33. R Development Core Team. R: a language and environment for statistical computing [cited 2005]. Vienna: R Foundation for Statistical Computing. Available from: http://www.R-project.org.
34. Considine RV, Nyce MR, Allen LE, Morales LM, Triester S, Serrano J, Colberg J, Lanza-Jacoby S, Caro JF. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. J Clin Invest. 1995;95:2938-44.
35. Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, Stevens RD, Bain JR, Newgard CB, Farese RV Sr, et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpression DGAT in the liver. Cell Metab. 2007;6:69-78.
36. Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am J Physiol Endocrinol Metab. 2002;282: E1180-90.
37. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Lièpvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferré P, et al. ADD1/ SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol. 1999;19:3760-8.
38. Dentin R, Denechaud PD, Benhamed F, Girard J, Postic C. Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP. J Nutr. 2006;136:1145-9.
39. Pégorier JP, Le May C, Girard J. Control of gene expression by fatty acids. J Nutr. 2004;134:S2444-9.
40. Buang Y, Wang YM, Cha JY, Nagao K, Yanagita T. Dietary phospha-tidylcholine alleviate fatty liver induced by orotic acid. Nutrition. 2005;21:867-73.
41. Shirouchi B, Nagao K, Inoue N, Furuya K, Koga S, Matsumoto H, Yanagita T. Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Agric Food Chem. 2008;56:2375-9.
42. American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc writing committee on standards for nutritional studies. J Nutr. 1977;107:1340-8.